首页> Frontiers in immunology> Prognostic significance of fludeoxyglucose positron emission tomography delta radiomics following bridging therapy in patients with large B-cell lymphoma undergoing CAR T-cell therapy.

Prognostic significance of fludeoxyglucose positron emission tomography delta radiomics following bridging therapy in patients with large B-cell lymphoma undergoing CAR T-cell therapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Colton,Ladbury

第一单位： Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA, United States.

作者： Colton,Ladbury ^[1] ; Claire,Hao ^[1] ; William Tyler,Watkins ^[1] ; Sagus,Sampath ^[1] ; Jeffrey,Wong ^[1] ; Arya,Amini ^[1] ; Karen,Sokolov ^[1] ; Jekwon,Yeh ^[1] ; Karine A,Al Feghali ^[2] ; Dorine,de Jong ^[2] ; Arjun,Maniyedath ^[2] ; Shervin,Shirvani ^[2] ; Liana,Nikolaenko ^[3] ; Matthew,Mei ^[3] ; Alex,Herrera ^[3] ; Leslie,Popplewell ^[3] ; Lihua Elizabeth,Budde ^[3] ; Savita,Dandapani ^[1]

作者单位： Department of Radiation Oncology, City of Hope National Medical Center, Duarte, CA, United States. ^[1] RefleXion Medical, Inc., Hayward, CA, United States. ^[2] Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, United States. ^[3]

关键词 bridging radiation chimeric antigen receptor T-cell (CAR T)delta radiomics large B-cell lymphoma (LBCL)positron emission tomography